CME Group Inc.

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, SPGI has a market cap of 170.7B. Regarding current trading prices, CME is priced at $281.35, while SPGI trades at $562.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas SPGI's P/E ratio is 42.98. In terms of profitability, CME's ROE is +0.14%, compared to SPGI's ROE of +0.12%. Regarding short-term risk, CME is less volatile compared to SPGI. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check SPGI's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, ICE has a market cap of 107.6B. Regarding current trading prices, CME is priced at $281.35, while ICE trades at $188.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas ICE's P/E ratio is 36.09. In terms of profitability, CME's ROE is +0.14%, compared to ICE's ROE of +0.11%. Regarding short-term risk, CME is more volatile compared to ICE. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check ICE's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, MCO has a market cap of 92.3B. Regarding current trading prices, CME is priced at $281.35, while MCO trades at $517.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas MCO's P/E ratio is 43.73. In terms of profitability, CME's ROE is +0.14%, compared to MCO's ROE of +0.56%. Regarding short-term risk, CME is more volatile compared to MCO. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check MCO's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, COIN has a market cap of 79.9B. Regarding current trading prices, CME is priced at $281.35, while COIN trades at $303.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas COIN's P/E ratio is 29.98. In terms of profitability, CME's ROE is +0.14%, compared to COIN's ROE of +0.28%. Regarding short-term risk, CME is less volatile compared to COIN. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check COIN's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, NDAQ has a market cap of 55.3B. Regarding current trading prices, CME is priced at $281.35, while NDAQ trades at $96.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas NDAQ's P/E ratio is 37.10. In terms of profitability, CME's ROE is +0.14%, compared to NDAQ's ROE of +0.13%. Regarding short-term risk, CME is more volatile compared to NDAQ. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check NDAQ's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, MSCI has a market cap of 42.2B. Regarding current trading prices, CME is priced at $281.35, while MSCI trades at $548.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas MSCI's P/E ratio is 36.11. In terms of profitability, CME's ROE is +0.14%, compared to MSCI's ROE of -1.33%. Regarding short-term risk, CME is less volatile compared to MSCI. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check MSCI's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, CBOE has a market cap of 26.1B. Regarding current trading prices, CME is priced at $281.35, while CBOE trades at $248.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas CBOE's P/E ratio is 29.32. In terms of profitability, CME's ROE is +0.14%, compared to CBOE's ROE of +0.20%. Regarding short-term risk, CME is less volatile compared to CBOE. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check CBOE's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, FDS has a market cap of 14.6B. Regarding current trading prices, CME is priced at $281.35, while FDS trades at $391.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas FDS's P/E ratio is 27.88. In terms of profitability, CME's ROE is +0.14%, compared to FDS's ROE of +0.26%. Regarding short-term risk, CME is less volatile compared to FDS. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check FDS's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, MORN has a market cap of 11B. Regarding current trading prices, CME is priced at $281.35, while MORN trades at $259.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas MORN's P/E ratio is 27.64. In terms of profitability, CME's ROE is +0.14%, compared to MORN's ROE of +0.25%. Regarding short-term risk, CME is less volatile compared to MORN. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check MORN's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, DNB has a market cap of 4.1B. Regarding current trading prices, CME is priced at $281.35, while DNB trades at $9.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas DNB's P/E ratio is -151.75. In terms of profitability, CME's ROE is +0.14%, compared to DNB's ROE of -0.01%. Regarding short-term risk, CME is more volatile compared to DNB. This indicates potentially higher risk in terms of short-term price fluctuations for CME.Check DNB's competition here

CME plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CME stands at 101.2B. In comparison, VALU has a market cap of 362.9M. Regarding current trading prices, CME is priced at $281.35, while VALU trades at $38.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CME currently has a P/E ratio of 27.20, whereas VALU's P/E ratio is 17.52. In terms of profitability, CME's ROE is +0.14%, compared to VALU's ROE of +0.21%. Regarding short-term risk, CME is less volatile compared to VALU. This indicates potentially lower risk in terms of short-term price fluctuations for CME.Check VALU's competition here